CT45A8
gene geneOn this page
Summary
CT45A8 (cancer/testis antigen family 45 member A8, HGNC:51261) is a protein-coding gene on chromosome Xq26.3, encoding Cancer/testis antigen family 45 member A8 (P0DMV1).
At a glance
- MANE Select transcript:
NM_001291535
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:51261 |
| Approved symbol | CT45A8 |
| Name | cancer/testis antigen family 45 member A8 |
| Location | Xq26.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000278085 |
| Ensembl biotype | protein_coding |
| Entrez | 102723737 |
Gene structure
Transcript identifiers
Ensembl transcripts: 2 — 2 protein_coding
ENST00000611438, ENST00000611660
RefSeq mRNA: 1 — MANE Select: NM_001291535
NM_001291535
CCDS: CCDS76033
Canonical transcript exons
ENST00000611660 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003726803 | 135848446 | 135848694 |
| ENSE00003737749 | 135846497 | 135846749 |
| ENSE00003742592 | 135847972 | 135848065 |
| ENSE00003746357 | 135854300 | 135854538 |
| ENSE00003751832 | 135850615 | 135850789 |
Expression profiles
Bgee: expression breadth broad, 24 present calls, max score 84.78.
Top tissues by expression
112 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.78 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 79.90 | gold quality |
| bone marrow cell | CL:0002092 | 38.58 | gold quality |
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| prefrontal cortex | UBERON:0000451 | 34.69 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| bone marrow | UBERON:0002371 | 32.98 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| tonsil | UBERON:0002372 | 29.28 | gold quality |
| liver | UBERON:0002107 | 28.85 | gold quality |
| frontal cortex | UBERON:0001870 | 28.79 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 28.19 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| substantia nigra | UBERON:0002038 | 27.94 | gold quality |
| primary visual cortex | UBERON:0002436 | 27.89 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| blood | UBERON:0000178 | 26.98 | silver quality |
| islet of Langerhans | UBERON:0000006 | 26.93 | gold quality |
| cerebral cortex | UBERON:0000956 | 26.48 | gold quality |
| nucleus accumbens | UBERON:0001882 | 26.44 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| temporal lobe | UBERON:0001871 | 26.24 | gold quality |
| amygdala | UBERON:0001876 | 26.15 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.14 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
18 targeting CT45A8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-4455 | 100.00 | 65.48 | 1587 |
| HSA-MIR-3148 | 99.97 | 75.06 | 6478 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-4668-5P | 99.79 | 70.58 | 3782 |
| HSA-MIR-586 | 99.65 | 70.40 | 2051 |
| HSA-MIR-4279 | 99.19 | 66.70 | 2437 |
| HSA-MIR-5006-5P | 98.79 | 66.92 | 1246 |
| HSA-MIR-5572 | 98.55 | 65.84 | 970 |
| HSA-MIR-6819-5P | 97.96 | 66.59 | 1071 |
| HSA-MIR-3151-3P | 97.80 | 66.16 | 479 |
| HSA-MIR-6737-5P | 97.75 | 66.54 | 1044 |
| HSA-MIR-6812-5P | 97.56 | 65.39 | 1059 |
| HSA-MIR-3674 | 97.01 | 68.86 | 1171 |
| HSA-MIR-6747-5P | 96.17 | 64.99 | 743 |
Cross-species orthologs
4 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Ct45a | ENSMUSG00000064016 |
| rattus_norvegicus | Ct45a9 | ENSRNOG00000048059 |
| drosophila_melanogaster | IntS6 | FBGN0261383 |
| caenorhabditis_elegans | WBGENE00000994 |
Paralogs (11): INTS6 (ENSG00000102786), INTS6L (ENSG00000165359), SAGE1 (ENSG00000181433), CT45A5 (ENSG00000228836), CT45A1 (ENSG00000268940), CT45A3 (ENSG00000269096), CT45A10 (ENSG00000269586), CT45A9 (ENSG00000270946), CT45A2 (ENSG00000271449), CT45A7 (ENSG00000273696), CT45A6 (ENSG00000278289)
Protein
Protein identifiers
Cancer/testis antigen family 45 member A8 — P0DMV1 (reviewed: P0DMV1)
Alternative names: Cancer/testis antigen 45A8
All UniProt accessions (1): P0DMV1
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the CT45 family.
RefSeq proteins (1): NP_001278464* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR029307 | INT_SG_DDX_CT_C | Domain |
| IPR051113 | Integrator_subunit6 | Family |
Pfam: PF15300
UniProt features (1 total): chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0DMV1-F1 | 68.94 | 0.15 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
chrXq26, HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_1_CELL, HE_LIM_SUN_FETAL_LUNG_C0_MYOFIBROBLAST_2_CELL
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| CT45A6 | AP3B1 | psi-mi:“MI:0914”(association) | 0.350 |
| APOM | CT45A8 | psi-mi:“MI:0914”(association) | 0.350 |
| FOXD4L1 | CT45A8 | psi-mi:“MI:0914”(association) | 0.350 |
ESM2 similar proteins: A0A097I2D0, A0A1W2PP81, A0A1W2PPE2, A0A1W2PPH5, A0A1W2PPL8, A0A1W2PPW3, A0A1W2PQ09, A0A1W2PR64, A0A1W2PRV1, A6NLC8, F4HR03, O54825, O75461, P0C1H6, P0CV38, P0DMV1, P0DMV2, P0DW11, P0DW12, P0DW13, P0DW14, P40914, P49585, P49906, P81195, Q0MTC0, Q13895, Q15544, Q2N2K6, Q3SZB8, Q5DJT8, Q5RA91, Q5U1X0, Q6CER9, Q6RG77, Q6XL73, Q75DE4, Q7XHR2, Q7Z2G1, Q80WL2
Diamond homologs: A6NJ88, P0DMU7, P0DMU8, P0DMU9, P0DMV0, P0DMV1, P0DMV2, Q2TAF4, Q5DJT8, Q5HYN5, Q5JSJ4, Q5U4W6, Q6PCM2, Q7SYD9, Q8BND4, Q8NHU0, Q9NXZ1, Q9UL03, Q54Z23, Q9W485
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS113137972 (X:135854173 G>A), RS1158630939 (X:135855592 G>A), RS1160448692 (X:135854873 C>T), RS1162619517 (X:135855729 G>A,T), RS1164813436 (X:135854882 T>A,C,G), RS1168430111 (X:135854956 A>G), RS1171163870 (X:135855192 C>G,T), RS1172255322 (X:135855831 G>A), RS1178183183 (X:135855567 C>T), RS1180693223 (X:135855864 AAGAG>A,AAG), RS1182487382 (X:135855350 C>A), RS1182892742 (X:135853089 A>T), RS1186427012 (X:135855738 A>AG), RS1186676422 (X:135855641 C>G,T), RS1187369973 (X:135855775 AAAGG>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.